| # | Title | Journal | Year | Citations |
|---|
| 1 | Epidemiology of breast cancer in Indian women | Asia-Pacific Journal of Clinical Oncology | 2017 | 429 |
| 2 | Health state utilities in non–small cell lung cancer: An international study | Asia-Pacific Journal of Clinical Oncology | 2017 | 169 |
| 3 | MG132, a proteasome inhibitor, induces apoptosis in tumor cells | Asia-Pacific Journal of Clinical Oncology | 2013 | 140 |
| 4 | Biomarkers and therapeutic advances in glioblastoma multiforme | Asia-Pacific Journal of Clinical Oncology | 2018 | 120 |
| 5 | Importance of health literacy in oncology | Asia-Pacific Journal of Clinical Oncology | 2012 | 106 |
| 6 | Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review | Asia-Pacific Journal of Clinical Oncology | 2019 | 100 |
| 7 | Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies | Asia-Pacific Journal of Clinical Oncology | 2018 | 92 |
| 8 | Prognostic factors and survival rate of osteosarcoma: A single‐institution study | Asia-Pacific Journal of Clinical Oncology | 2017 | 74 |
| 9 | Review of high‐dose intravenous vitamin C as an anticancer agent | Asia-Pacific Journal of Clinical Oncology | 2014 | 70 |
| 10 | Strain‐specific probiotic (microbial cell preparation) and omega‐3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial | Asia-Pacific Journal of Clinical Oncology | 2018 | 70 |
| 11 | End‐of‐life care: Where do cancer patients want to die? A systematic review | Asia-Pacific Journal of Clinical Oncology | 2017 | 69 |
| 12 | Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance | Asia-Pacific Journal of Clinical Oncology | 2021 | 69 |
| 13 | Epidemiology, screening and diagnosis of breast cancer in the Asia–Pacific region: Current perspectives and important considerations | Asia-Pacific Journal of Clinical Oncology | 2008 | 66 |
| 14 | The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia | Asia-Pacific Journal of Clinical Oncology | 2010 | 63 |
| 15 | Cancer survival and prevalence in Australia: Period estimates from 1982 to 2010 | Asia-Pacific Journal of Clinical Oncology | 2013 | 63 |
| 16 | Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers | Asia-Pacific Journal of Clinical Oncology | 2018 | 62 |
| 17 | Microsatellite instability in colorectal cancer | Asia-Pacific Journal of Clinical Oncology | 2010 | 61 |
| 18 | Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissue | Asia-Pacific Journal of Clinical Oncology | 2013 | 60 |
| 19 | Could yoga practice improve treatment‐related side effects and quality of life for women with breast cancer? A systematic review and meta‐analysis | Asia-Pacific Journal of Clinical Oncology | 2017 | 60 |
| 20 | An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic | Asia-Pacific Journal of Clinical Oncology | 2021 | 59 |
| 21 | Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection | Asia-Pacific Journal of Clinical Oncology | 2010 | 58 |
| 22 | Comorbidity, physical and mental health among cancer patients and survivors: An Australian population‐based study | Asia-Pacific Journal of Clinical Oncology | 2018 | 56 |
| 23 | Treatment‐related toxicities of immune checkpoint inhibitors in advanced cancers: A meta‐analysis | Asia-Pacific Journal of Clinical Oncology | 2018 | 54 |
| 24 | Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival | Asia-Pacific Journal of Clinical Oncology | 2016 | 52 |
| 25 | Probiotics reduce psychological stress in patients before laryngeal cancer surgery | Asia-Pacific Journal of Clinical Oncology | 2016 | 52 |
| 26 | Exercise therapy in oncology rehabilitation in Australia: A mixed‐methods study | Asia-Pacific Journal of Clinical Oncology | 2017 | 52 |
| 27 | Insights into the cell of origin in breast cancer and breast cancer stem cells | Asia-Pacific Journal of Clinical Oncology | 2010 | 51 |
| 28 | Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer | Asia-Pacific Journal of Clinical Oncology | 2010 | 50 |
| 29 | Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer | Asia-Pacific Journal of Clinical Oncology | 2015 | 50 |
| 30 | Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer | Asia-Pacific Journal of Clinical Oncology | 2016 | 49 |
| 31 | The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer | Asia-Pacific Journal of Clinical Oncology | 2018 | 49 |
| 32 | Salivary interleukin‐6 in the detection of oral cancer and precancer | Asia-Pacific Journal of Clinical Oncology | 2015 | 48 |
| 33 | Effect of C‐reactive protein/albumin ratio on prognosis in advanced non–small‐cell lung cancer | Asia-Pacific Journal of Clinical Oncology | 2018 | 48 |
| 34 | Elevated neutrophil‐to‐lymphocyte ratio predicts poor outcome in patients with advanced non‐small‐cell lung cancer receiving first‐line gefitinib or erlotinib treatment | Asia-Pacific Journal of Clinical Oncology | 2017 | 47 |
| 35 | Cancer multidisciplinary team meetings in practice: Results from a multi‐institutional quantitative survey and implications for policy change | Asia-Pacific Journal of Clinical Oncology | 2018 | 47 |
| 36 | Impact of body mass index and visceral adiposity on outcomes in colorectal cancer | Asia-Pacific Journal of Clinical Oncology | 2012 | 45 |
| 37 | Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression | Asia-Pacific Journal of Clinical Oncology | 2016 | 45 |
| 38 | Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017 | Asia-Pacific Journal of Clinical Oncology | 2018 | 45 |
| 39 | Medical and non‐medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross‐sectional study | Asia-Pacific Journal of Clinical Oncology | 2018 | 45 |
| 40 | Evidence on the economic value of psychosocial interventions to alleviate anxiety and depression among cancer survivors: A systematic review | Asia-Pacific Journal of Clinical Oncology | 2011 | 44 |
| 41 | Evaluation of the safety, pharmacokinetics and treatment effects of an ανβ3 integrin inhibitor on bone turnover and disease activity in men with hormone‐refractory prostate cancer and bone metastases | Asia-Pacific Journal of Clinical Oncology | 2010 | 43 |
| 42 | Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy | Asia-Pacific Journal of Clinical Oncology | 2012 | 43 |
| 43 | Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities | Asia-Pacific Journal of Clinical Oncology | 2018 | 43 |
| 44 | PD‐L1 expression associated with worse survival outcome in malignant pleural mesothelioma | Asia-Pacific Journal of Clinical Oncology | 2018 | 43 |
| 45 | Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non‐squamous non‐small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial | Asia-Pacific Journal of Clinical Oncology | 2011 | 42 |
| 46 | Phase III, randomized, open‐label, first‐line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non‐small‐cell lung cancer: evaluation of patients recruited from mainland China | Asia-Pacific Journal of Clinical Oncology | 2012 | 42 |
| 47 | Navigating the cancer journey: A review of patient navigator programs for Indigenous cancer patients | Asia-Pacific Journal of Clinical Oncology | 2012 | 42 |
| 48 | Medical models of teleoncology: Current status and future directions | Asia-Pacific Journal of Clinical Oncology | 2014 | 42 |
| 49 | Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study | Asia-Pacific Journal of Clinical Oncology | 2015 | 42 |
| 50 | CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non–small cell lung cancer | Asia-Pacific Journal of Clinical Oncology | 2018 | 42 |
